TMC Life Sciences Bhd
KLSE:TMCLIFE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.5
0.805
|
Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TMCLIFE stock under the Base Case scenario is 0.63 MYR. Compared to the current market price of 0.51 MYR, TMC Life Sciences Bhd is Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
TMC Life Sciences Bhd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TMCLIFE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
TMC Life Sciences Bhd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
TMC Life Sciences Bhd
Balance Sheet Decomposition
TMC Life Sciences Bhd
Current Assets | 273.6m |
Cash & Short-Term Investments | 192.5m |
Receivables | 69.4m |
Other Current Assets | 11.7m |
Non-Current Assets | 922.3m |
Long-Term Investments | 2.1m |
PP&E | 715.8m |
Intangibles | 204.5m |
Current Liabilities | 97.5m |
Accounts Payable | 74.5m |
Other Current Liabilities | 22.9m |
Non-Current Liabilities | 211.5m |
Long-Term Debt | 188.1m |
Other Non-Current Liabilities | 23.4m |
Earnings Waterfall
TMC Life Sciences Bhd
Revenue
|
346.4m
MYR
|
Cost of Revenue
|
-101.3m
MYR
|
Gross Profit
|
245.1m
MYR
|
Operating Expenses
|
-187.7m
MYR
|
Operating Income
|
57.4m
MYR
|
Other Expenses
|
-16.7m
MYR
|
Net Income
|
40.6m
MYR
|
Free Cash Flow Analysis
TMC Life Sciences Bhd
MYR | |
Free Cash Flow | MYR |
TMCLIFE Profitability Score
Profitability Due Diligence
TMC Life Sciences Bhd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
TMC Life Sciences Bhd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
TMCLIFE Solvency Score
Solvency Due Diligence
TMC Life Sciences Bhd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
TMC Life Sciences Bhd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TMCLIFE Price Targets Summary
TMC Life Sciences Bhd
Dividends
Current shareholder yield for TMCLIFE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
TMC Life Sciences Bhd.operates as an investment holding company. The company is headquartered in Petaling Jaya, Selangor and currently employs 1,108 full-time employees. The company went IPO on 2005-10-06. The firm's subsidiaries include IVF Technologies Sdn. Bhd., which is a provision of fertility services and operation of women’s clinic; TMC Biotech Sdn. Bhd., which is a provision of fertility consultancy, laboratory and embryology services and research and development; TMC Lifestyle Sdn. Bhd., which is developing, marketing and management of healthcare programs; TMC Properties Sdn. Bhd., which is a property investment; Thomson TCM Sdn. Bhd., which is a provides traditional and complementary services; BB Waterfront Sdn. Bhd., which provides healthcare services, TMC Women’s Specialist Holdings Sdn. Bhd., which is in the business of operating fertility centers and providing related services, and TMC Care Sdn. Bhd., which is engaged in the provision of pharmacy services and products, and management support services.
Contact
IPO
Employees
Officers
The intrinsic value of one TMCLIFE stock under the Base Case scenario is 0.63 MYR.
Compared to the current market price of 0.51 MYR, TMC Life Sciences Bhd is Undervalued by 19%.